Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 36

Sort by

Sort Order Select

Journal Articles

Elevated serum levels of IL-2R, IL-1RA, and CXCL9 are associated with a poor prognosis in follicular lymphoma

Muhammad A. Mir, Matthew J. Maurer, Steven C. Ziesmer, Susan L. Slager, Thomas Habermann, William R. Macon, Brian K. Link, Sergei Syrbu, Thomas Witzig, Jonathan W. Friedberg, Oliver Press, Michael LeBlanc, James R. Cerhan, Anne Novak, Stephen M. Ansell

Blood (2015) 125 (6): 992–998.

https://doi.org/10.1182/blood-2014-06-583369

Published: 2015

Includes: Supplemental data

Journal Articles

GATA-3 expression identifies a high-risk subset of PTCL, NOS with distinct molecular and clinical features

Tianjiao Wang, Andrew L. Feldman, David A. Wada, Ye Lu, Avery Polk, Robert Briski, Kay Ristow, Thomas M. Habermann, Dafydd Thomas, Steven C. Ziesmer, Linda E. Wellik, Thomas M. Lanigan, Thomas E. Witzig, Mark R. Pittelkow, Nathanael G. Bailey, Alexandra C. Hristov, Megan S. Lim, Stephen M. Ansell, Ryan A. Wilcox

Blood (2014) 123 (19): 3007–3015.

https://doi.org/10.1182/blood-2013-12-544809

Published: 2014

Includes: Supplemental data

Journal Articles

Constitutive activation of STAT5A and STAT5B regulates IgM secretion in Waldenström's macroglobulinemia

Lucy S. Hodge, Steven C. Ziesmer, Zhi-Zhang Yang, Frank J. Secreto, Anne J. Novak, Stephen M. Ansell

Blood (2014) 123 (7): 1055–1058.

https://doi.org/10.1182/blood-2013-08-521963

Published: 2014

Journal Articles

Interactions Between PD-1 and PD-L1 and PD-L2 Promote Malignant B-Cell Growth in Waldenstrom Macroglobulinemia

Deanna M. Grote, Steven C. Ziesmer, Lucy S. Hodge, PharmD, Ph.D., Tammy L. Price-Troska, Anne J. Novak, Ph.D., Zhi-Zhang Yang, MD, Stephen M Ansell, M.D.Ph.D.

Blood (2013) 122 (21): 4334.

https://doi.org/10.1182/blood.V122.21.4334.4334

Published: 2013

Journal Articles

PD-1 Expression Defines Two Distinct T-Cell Subpopulations That Differentially Impact Patient Outcomes In Follicular Lymphoma

Zhi-Zhang Yang, MD, Deanna M. Grote, Steven C. Ziesmer, Stephen M Ansell, M.D.Ph.D.

Blood (2013) 122 (21): 366.

https://doi.org/10.1182/blood.V122.21.366.366

Published: 2013

Journal Articles

GATA-3 Expression Promotes IL-10 Production, Alternative Macrophage Polarization, and Identifies a Subset Of High-Risk PTCL, NOS

Tianjiao Wang, Ph.D., Andrew L. Feldman, David A Wada, MD, Ye Lu, MD, Avery Polk, BS, Robert Briski, BS, Kay M. Ristow, Thomas M Habermann, MD, Dafydd G Thomas, MD/Ph.D., Steven C. Ziesmer, Linda E Wellik, Thomas Lanigan, Ph.D., Thomas E Witzig, MD, Mark Pittelkow, MD, Nathanael G. Bailey, MD, Megan Lim, MD, PhD, Stephen M Ansell, M.D.Ph.D., Ryan A. Wilcox, MD, PhD

Blood (2013) 122 (21): 841.

https://doi.org/10.1182/blood.V122.21.841.841

Published: 2013

Journal Articles

Biologic Activity of STAT5A and STAT5B in Waldenstrom's Macroglobulinemia.

Lucy S. Hodge, PharmD, Ph.D., Steven C. Ziesmer, Frank J Secreto, Ph.D., Zhi-Zhang Yang, MD, Anne J. Novak, Ph.D., Stephen M. Ansell, M.D., Ph.D.

Blood (2012) 120 (21): 2688.

https://doi.org/10.1182/blood.V120.21.2688.2688

Published: 2012

Journal Articles

MYD88 Pathway Activation in Lymphoplasmacytic Lymphoma Drives Tumor Cell Growth and Cytokine Expression.

Stephen M Ansell, M.D., Ph.D., Frank J Secreto, Ph.D., Michelle Manske, Esteban Braggio, Ph.D., Lucy S. Hodge, PharmD, Ph.D., Tammy Price-Troska, Steven C. Ziesmer, Asher Alban Chanan-Khan, M.D., Morie A Gertz, M.D., Ahmet Dogan, MD, PhD, James R Cerhan, MD, PhD, Anne J Novak, Ph.D.

Blood (2012) 120 (21): 2699.

https://doi.org/10.1182/blood.V120.21.2699.2699

Published: 2012

Journal Articles

The Presence of Intratumoral CD14 Positive Cells Is Associated with Transformation of Follicular Lymphoma to Diffuse Large B Cell Lymphoma.

Jason M. Jones, MD, Ahmet Dogan, MD, PhD, Steven C. Ziesmer, Grzegorz S. Nowakowski, MD, Kay M. Ristow, Zhi-Zhang Yang, MD, James R Cerhan, MD, PhD, Stephen M. Ansell, M.D., Ph.D.

Blood (2012) 120 (21): 2700.

https://doi.org/10.1182/blood.V120.21.2700.2700

Published: 2012

Journal Articles

Pretreatment Serum Cytokines Predict Early Disease Relapse and A Poor Prognosis In Newly Diagnosed Classical Hodgkin Lymphoma (cHL) Patients

Stephen M. Ansell, MD, PhD, Matthew J Maurer, MS, Steven C. Ziesmer, Susan L Slager, PhD, Thomas M. Habermann, MD, Brian K Link, MD, Thomas E. Witzig, MD, David James Inwards, MD, Joseph P. Colgan, MD, James R Cerhan, MD, PhD, Anne J. Novak, Ph.D.

Blood (2011) 118 (21): 429.

https://doi.org/10.1182/blood.V118.21.429.429

Published: 2011

Journal Articles

UCH-L1 Is a Novel Regulator of mTOR Signaling That May Predict a Poor Response to mTOR Inhibition in Patients with B-Cell Lymphoma,

Sajjad Hussain, PhD, Steven C. Ziesmer, Andrew L. Feldman, MD, Stephen M. Ansell, MD, PhD, Paul J. Galardy, MD

Blood (2011) 118 (21): 3691.

https://doi.org/10.1182/blood.V118.21.3691.3691

Published: 2011

Journal Articles

Elevated Serum IL-10 Levels in Patients with Diffuse Large B Cell Lymphoma: A Mechanism of Aberrant JAK2 Kinase Activation

Mamta Gupta, Ph.D, Mary Stenson, Jing Jing Han, Matthew J Maurer, MS, Linda Wellik, Steven C. Ziesmer, Ahmet Dogan, Thomas E. Witzig, MD

Blood (2011) 118 (21): 960.

https://doi.org/10.1182/blood.V118.21.960.960

Published: 2011

Journal Articles

A Lymphoma-Associated Mutation in BAFF-R Drives Constitutive PI3K Signaling and Increased Expression of Pro-Survival Genes

Frank J Secreto, Michelle K Manske, Tammy Price-Troska, Steven C. Ziesmer, Stephen M Ansell, MD, James R Cerhan, MD, PhD, Anne J. Novak, Ph.D.

Blood (2011) 118 (21): 2642.

https://doi.org/10.1182/blood.V118.21.2642.2642

Published: 2011

Journal Articles

TGF-β Is Selectively Expressed on Lymphoma B Cells and Regulates the Differentiation of Intratumoral T Cells in B-Cell Non-Hodgkin Lymphoma (NHL)

Zhi-Zhang Yang, MD, Deanna Grote, Steven C. Ziesmer, Thomas E. Witzig, MD, Anne J. Novak, Ph.D., Stephen M. Ansell, MD, PhD

Blood (2011) 118 (21): 1586.

https://doi.org/10.1182/blood.V118.21.1586.1586

Published: 2011

Journal Articles

Comprehensive analysis of tumor microenvironment cytokines in Waldenstrom macroglobulinemia identifies CCL5 as a novel modulator of IL-6 activity

Sherine F. Elsawa, Anne J. Novak, Steven C. Ziesmer, Luciana L. Almada, Lucy S. Hodge, Deanna M. Grote, Thomas E. Witzig, Martin E. Fernandez-Zapico, Stephen M. Ansell

Blood (2011) 118 (20): 5540–5549.

https://doi.org/10.1182/blood-2011-04-351742

Published: 2011

Journal Articles

Soluble IL-2Rα facilitates IL-2–mediated immune responses and predicts reduced survival in follicular B-cell non-Hodgkin lymphoma

Zhi-Zhang Yang, Deanna M. Grote, Steven C. Ziesmer, Michelle K. Manske, Thomas E. Witzig, Anne J. Novak, Stephen M. Ansell

Blood (2011) 118 (10): 2809–2820.

https://doi.org/10.1182/blood-2011-03-340885

Published: 2011

Journal Articles

Establishment and characterization of a novel Waldenström macroglobulinemia cell line, MWCL-1

Lucy S. Hodge, Anne J. Novak, Deanna M. Grote, Esteban Braggio, Rhett P. Ketterling, Michelle K. Manske, Tammy L. Price Troska, Steven C. Ziesmer, Rafael Fonseca, Thomas E. Witzig, William G. Morice, Morie A. Gertz, Stephen M. Ansell

Blood (2011) 117 (19): e190–e197.

https://doi.org/10.1182/blood-2010-12-326868

Published: 2011

Includes: Supplemental data

Journal Articles

Pretreatment Serum Cytokines Predict Early Disease Relapse and a Poor Prognosis In Diffuse Large B-Cell Lymphoma (DLBCL) Patients

Stephen M. Ansell, MD, PhD, Matthew J Maurer, Steven C Ziesmer, Susan L Slager, PhD, Thomas M Habermann, MD, Brian Link, Thomas E Witzig, MD, James Cerhan, MD, PhD, Anne J. Novak, PhD

Blood (2010) 116 (21): 991.

https://doi.org/10.1182/blood.V116.21.991.991

Published: 2010

Journal Articles

Inhibition of the Jak/Stat Pathway Downregulates Immunoglobulin Production and Induces Cell Death in Waldenström Macroglobulinemia.

Stephen M Ansell, Deanna Grote, Sherine F. Elsawa, PhD, Mamta Gupta, PhD, Steven C Ziesmer, Anne J Novak, PhD, Thomas E Witzig, MD

Blood (2009) 114 (22): 1691.

https://doi.org/10.1182/blood.V114.22.1691.1691

Published: 2009

Journal Articles

Elevated Serum IL-12 Levels Attenuate Tumor Immunity Via the TIM-3/Gal-9 Axis and Worsen Patient Prognosis in Follicular B-Cell Non-Hodgkin Lymphoma (NHL).

Zhi-Zhang Yang, Steven C. Ziesmer, Anne J. Novak, PhD, Toshiro Niki, Mitsuomi Hirashima, MD, PhD, Thomas E. Witzig, Stephen M Ansell

Blood (2009) 114 (22): 2668.

https://doi.org/10.1182/blood.V114.22.2668.2668

Published: 2009

NARROW

Elevated serum levels of IL-2R, IL-1RA, and CXCL9 are associated with a poor prognosis in follicular lymphoma

GATA-3 expression identifies a high-risk subset of PTCL, NOS with distinct molecular and clinical features

Constitutive activation of STAT5A and STAT5B regulates IgM secretion in Waldenström's macroglobulinemia

Interactions Between PD-1 and PD-L1 and PD-L2 Promote Malignant B-Cell Growth in Waldenstrom Macroglobulinemia

PD-1 Expression Defines Two Distinct T-Cell Subpopulations That Differentially Impact Patient Outcomes In Follicular Lymphoma

GATA-3 Expression Promotes IL-10 Production, Alternative Macrophage Polarization, and Identifies a Subset Of High-Risk PTCL, NOS

Biologic Activity of STAT5A and STAT5B in Waldenstrom's Macroglobulinemia.

MYD88 Pathway Activation in Lymphoplasmacytic Lymphoma Drives Tumor Cell Growth and Cytokine Expression.

The Presence of Intratumoral CD14 Positive Cells Is Associated with Transformation of Follicular Lymphoma to Diffuse Large B Cell Lymphoma.

Pretreatment Serum Cytokines Predict Early Disease Relapse and A Poor Prognosis In Newly Diagnosed Classical Hodgkin Lymphoma (cHL) Patients

UCH-L1 Is a Novel Regulator of mTOR Signaling That May Predict a Poor Response to mTOR Inhibition in Patients with B-Cell Lymphoma,

Elevated Serum IL-10 Levels in Patients with Diffuse Large B Cell Lymphoma: A Mechanism of Aberrant JAK2 Kinase Activation

A Lymphoma-Associated Mutation in BAFF-R Drives Constitutive PI3K Signaling and Increased Expression of Pro-Survival Genes

TGF-β Is Selectively Expressed on Lymphoma B Cells and Regulates the Differentiation of Intratumoral T Cells in B-Cell Non-Hodgkin Lymphoma (NHL)

Comprehensive analysis of tumor microenvironment cytokines in Waldenstrom macroglobulinemia identifies CCL5 as a novel modulator of IL-6 activity

Soluble IL-2Rα facilitates IL-2–mediated immune responses and predicts reduced survival in follicular B-cell non-Hodgkin lymphoma

Establishment and characterization of a novel Waldenström macroglobulinemia cell line, MWCL-1

Pretreatment Serum Cytokines Predict Early Disease Relapse and a Poor Prognosis In Diffuse Large B-Cell Lymphoma (DLBCL) Patients

Inhibition of the Jak/Stat Pathway Downregulates Immunoglobulin Production and Induces Cell Death in Waldenström Macroglobulinemia.

Elevated Serum IL-12 Levels Attenuate Tumor Immunity Via the TIM-3/Gal-9 Axis and Worsen Patient Prognosis in Follicular B-Cell Non-Hodgkin Lymphoma (NHL).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only